On the other hand, loss of TGF-β receptors may weaken TGF-β-induced apoptosis, enhance cytokine secretion, and in inflammatory bowel disease promote the papilloma transformation and tumor angiogenesis [10], [15], [18], [25]–[27]. This evidence concerns the gene TGFB1 and papilloma.